Talent

Sanford-Burnham has reached new heights of excellence, thanks to our outstanding talent. Our entrepreneurial spirit fuels scientific discoveries that become tomorrow's cures.

- Kristiina Vuori, M.D., Ph.D.

President, Sanford-Burnham Medical Research Institute

Talent - Quote Read More
25
  • All
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

Robert Abraham, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Abraham investigates a variety of intracellular signaling pathways related to cell-cycle control and cancer development.

Cristian Achim, M.D., Ph.D.

Adjunct Associate Professor

Dr. Achim's research interests included experimental models of neurodegeneration, neuroprogenitor cells, neurotrophic factors, blood brain barrier pathology and neuroimaging.

Eileen Adamson, Ph.D.

Emeritus Professor

Dr. Adamson’s laboratory is working on a new way to find out which genes in cancer are deregulated using a method that scans thousands of genes at a time in a novel modification of a process called "high throughput microarray analysis".

Salvatore Albani, M.D., Ph.D.

Director, Translational Research for Infectious and Inflammatory Disease Center
Adjunct Professor

Dr. Albani studies the mechanisms of autoimmune diseases, and develops new strategies to re-direct T-cell responses.

Judith Altarejos, Ph.D.

Assistant Professor
Metabolic Disease Program

Dr. Altarejos studies how peripheral signals modulate energy balance through the regulation of gene expression in the hypothalamus.

Rajesh Ambasudhan, Ph.D.

Research Assistant Professor, Neuroscience and Aging Research Center
Development, Aging, and Regeneration Program

Julio Ayala, Ph.D.

Associate Director, Cardiometabolic Phenotyping Core
Assistant Professor
Metabolic Disease Program

Dr. Ayala’s research focuses on the role of the incretin hormone glucagon-like peptide-1 (Glp-1) and its receptor in the regulation of fuel metabolism.

C

Clyde Campbell, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

He plans to utilize his experiences to help develop new genetic tools to manipulate gene function and elucidate the mechanisms involved in diseases associated with the liver and pancreas.

Robert  Cardiff, M.D., Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Sumit Chanda, Ph.D.

Professor
Immunity and Pathogenesis Program

Dr. Chanda's laboratory is working to elucidate the repertoire of host proteins required for host-pathogen interaction, as well as cellular control of immune responses.

Huei-Sheng Vincent Chen, Ph.D.

Associate Professor
Development, Aging, and Regeneration Program

Dr. Chen investigates the factors controlling development, maturation and function of various ion channels in cardiac and neurological systems to develop pharmacological and therapeutic interventions for cardiac arrhythmia, cardiomyopathy, and neurodegenerative diseases using stem cell-based approaches.

Su-Li Cheng, Ph.D.

Research Assistant Professor

Dr. Cheng studies the roles of canonical Wnt signaling in cardiovascular function in diabetes.

Thomas "TC" Chung, Ph.D.

Director of Outreach, Strategic Alliances & Partnerships
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Dr. Chung is the Director of Outreach, Strategic Alliances & Partnerships at the Sanford-Burnham Medical Research Institute's screening center.

Piotr Cieplak, Ph.D.

Research Associate Professor

Giuseppina Claps, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Giuseppina is interested in define specific markers for normal prostate stem cells (PSCs) applying new methods.

Paul Coen, Ph.D.

Adjunct Assistant Professor
Metabolic Disease Program

Dr. Coen studies how mitochondria and sphingolipid metabolism contribute to sarcopenia and insulin resistance in aging.

Sheila Collins, Ph.D.

Professor
Metabolic Disease Program

Dr. Collins's laboratory is interested in the biochemical mechanisms that regulate body weight, and is currently studying the role adrenaline receptors play in the breakdown of stored fat and the development of white vs. brown adipocytes.

Cosimo Commisso, Ph.D.

Assistant Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Commisso analyzes the function of macropinocytosis, an endocytic mechanism of fluid uptake, in Ras-driven cancers.

Nicholas Cosford, Ph.D.

Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Cosford’s laboratory uses medicinal chemistry, chemical biology, rational drug design and microfluidic approaches to develop small-molecule modulators of cell death, survival and growth signaling pathways, for use as novel therapeutic agents to treat cancer, neurodegenerative and psychiatric disorders, and orphan diseases.

Sara A. Courtneidge, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Courtneidge studies Src and its substrates and their roles in invadopodia/podosome formation, cancer progression and embryonic development.

Paula Coutino, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Paula’s goal is to elucidate the individual role of Brm and Brg1-containing SWI/SNF complexes during myoblast differentiation.

Peter Crawford, M.D., Ph.D.

Associate Professor
Associate Director, Cardiovascular Pathobiology Program

Dr. Crawford’s group uses chemical profiling methods to study how fuels are shared and metabolized among organs in homeostasis and disease

D

Maximiliano D’Angelo, Ph.D.

Assistant Professor
Development, Aging, and Regeneration Program

Dr. D’Angelo studies the basic biology of Nuclear Pore Complexes, the protein channels that connect the nucleus with the cytoplasm, and is interested in understanding how alterations in these structures contribute to tissue malfunction, aging and disease development.

Alessandra Dall'Agnese, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Marcia Dawson, Ph.D.

Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Dawson's laboratory uses rational drug design and computational methods to understand small-molecule-protein interactions, with the goal of designing, synthesizing and optimizing new pro-apoptotic small molecules and retinoic acid analogs.

Roisin Delaney, M.Pharm

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Roisin Delaney will be researching the regulation of Ras signaling for cancer therapy.

Anthony DeMaria, M.D.

Adjunct Associate Professor

Ani Deshpande, Ph.D.

Assistant Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Ani Deshpande investigates epigenetic mechanisms (genome modifications) that drive normal and malignant stem cell development.

Maria Diaz-Meco, Ph.D.

Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Diaz-Meco’s research focuses on the role of the atypical protein kinase C (aPKC) pathway in cancer and inflammation.

Yi Ding, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Yi Ding is interested in understanding structure and function of membrane protein, especially bacterial membrane protein.

Duc Dong, Ph.D.

Assistant Professor
Human Genetics Program

Dr. Dong’s goal is to uncover fundamental insight into basic and biomedical science through the rigorous investigation of the genetic mechanisms governing organogenesis and disease.

Gregg Duester, Ph.D.

Professor, Center for Stem Cell Biology and Regenerative Medicine
Development, Aging, and Regeneration Program

Dr. Duester studies the function of the vitamin A metabolite retinoic acid during embryonic development and stem cell differentiation, as a step toward understanding the causes and potential treatments of human birth defects and aging.

F

Maria Fahd, BMedSci, MBBS

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Maria is interested in translational research in leukemia and lymphoma, cellular therapies, and transfusion medicine.

Domenico Fasci, Ph.D.

Postdoctoral Fellow

Domenico Fasci is interested in the study of the SUMOylation/deSUMOylation cycle.

Darren Finlay, Ph.D.

Research Assistant Professor, NCI-Designated Cancer Center

Dr. Finlay's research is focused on apoptosis (programmed cell death) and how this process can be manipulated to kill cancer cells.

Rati Fotedar, Ph.D.

Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Fotedar's laboratory is working to gain a better understanding of cell cycle checkpoints and how they link DNA damage and repair, cell cycle progression, cell senescence and apoptosis.

Hudson Freeze, Ph.D.

Professor
Director, Human Genetics Program

Dr. Freeze focuses on identifying the genetic causes of Congenital Disorders of Glycosylation (CDG) and other diseases that involve glycosylation, and how these defects translate into disease presentation and treatment.

Michiko Fukuda, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Fukuda's laboratory is investigating the role of glycoproteins and cell surface carbohydrates in fertility, embryonic implantation and cancer metastasis.

Minoru Fukuda, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Fukuda's research focuses on the cell-type specific carbohydrates including sialyl-Lewis X and their roles in cell adhesion, leukocyte homing, tumor metastasis, inflammation and infectious disease.

G

Stephen Gardell, Ph.D.

Senior Director of Scientific Resources at Lake Nona
Associate Professor
Cardiovascular Pathobiology Program

Dr. Gardell directs an array of translational research technology platforms that facilitate the adancement of basic scientific discoveries from Sanford-Burnham laboratories toward potential clinical utility.

Sara Gelino, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Sara Gelino is interested in the role of autophagy in the longevity pathway of dietary restriction.

Gregory Gibson, Ph.D.

Adjunct Professor

Lorenzo Giordani, M.S.

Alumnus/a, Sanford-Burnham Graduate School of Biomedical Sciences

Lorenzo is interested in mechanism by which epigenetic events are integrated at the chromatin level to determine the sub-sets of genes that are expressed upon the commitment of embryonic or adult stem cells toward specific cell lineages.

Adam Godzik, Ph.D.

Professor
Director, Bioinformatics and Structural Biology Program

Dr. Godzik's research focuses on biological systems and their evolution.

Vladislav Golubkov, Ph.D.

Research Assistant Professor

The emphasis of Dr. Golubkov's research is on the metalloprotease (MMP)-dependent oncogenesis and invasion of malignant cells.

Monica Gonzalez, B.S., M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

My research focuses on discovering caspase substrates critical in the cell survival function of caspase-8.

Bret Goodpaster, Ph.D.

Professor
Metabolic Disease Program

Dr. Goodpaster’s primary research interests are exercise, skeletal muscle metabolism in obesity, Type 2 diabetes and aging, and the association between muscle composition and its function in aging.

Paul Grossfield, M.D.

Adjunct Assistant Professor

Gabriel Guerrero, B.A.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Gabriel’s research focuses on the role of endoplasmic reticulum (ER) stress and the unfolded protein response (UPR) in the function and homeostasis of intestinal epithelial cells (IECs).

Mirco Guigli, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Mirco is mainly interested in cell-image-based high content screens (HCS).

Tod Gulick, M.D.

Adjunct Associate Professor
Cardiovascular Pathobiology Program

Dr. Gulick investigates alternative splicing of transcription factors and expression and functions of the encoded splicing isoforms in muscle.

Anjali Gupta, B.S., M.S., M.B.A.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Anjali is interested in studying genetics. She has a background in pharmaceutical research and marketing.

H

Janna Hachmann, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Janna Hachmann is interested in the oncogene known as MALT1, which plays a crucial role in certain forms of lymphoma.

Gabriel Haddad, M.D.

Adjunct Associate Professor

Xianlin  Han, Ph.D.

Professor
Cardiovascular Pathobiology Program

Dr. Han's laboratory focuses on identifying the biochemical mechanism(s) underlying the altered lipid metabolism, trafficking, and homeostasis under patho(physio)logical conditions including metabolic syndrome and Alzheimer’s disease by using a lipidomics approach.

Dorit Hanein, Ph.D.

Professor
Bioinformatics and Structural Biology Program

Dr. Hanein's group employs electron microscopy, electron tomography and three-dimensional image analysis to determine the structures of macromolecular machines, ultimately in their native context and environment.

Malene Hansen, Ph.D.

Associate Professor
Development, Aging, and Regeneration Program

Dr. Hansen focuses on the modulation of aging and age-related disease by evolutionary conserved signaling pathways.

Christian Hassig, Ph.D.

Director for Drug Discovery (La Jolla)
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Chris provides operational and scientific oversight of the activities of the Conrad Prebys Center for Chemical Genomics.

Craig Hauser, Ph.D.

Vice President for Scientific Resources;
Cancer Center Associate Director, Shared Resources
Adjunct Associate Professor, NCI-Designated Cancer Center

Dr. Hauser’s research has centered on the interplay between the regulation of gene expression and oncogenic transformation.

Susanne Heynen-Genel, Ph.D.

Director, High Content Screening Systems
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Susan directs development and execution of image-based high-content assays for high-throughput screening (primary screens of large chemical and RNAi libraries) and small scale screening (secondary assays, focused libraries, assays for validation of basic research findings)

James Hickman, Ph.D.

Adjunct Professor
Cardiovascular Pathobiology Program

Ziwei Huang, Ph.D.

Adjunct Professor

Sarah Hudson, Ph.D.

Associate Director of Portfolio Project Management
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Sarah is in charge of the center-wide implementation and customization of a web-based project/portfolio management system at the Prebys Center.

K

Randal Kaufman, Ph.D.

Professor
Director, Degenerative Diseases Program

Dr. Kaufman’s current research is focused on understanding the fundamental mechanisms that regulate protein folding and the cellular responses to the accumulation of unfolded proteins within the endoplasmic reticulum.

Marcus Kaul, Ph.D.

Assistant Professor
Immunity and Pathogenesis Program

Dr. Kaul's work focuses on the role of chemokines, inflammatory cytokines and their receptors in inflammatory and degenerative diseases, including the promotion or prevention of HIV-associated neurodegeneration and dementia.

Daniel Kelly, M.D.

Tavistock Distinguished Professor and Scientific Director, Sanford-Burnham Medical Research Institute at Lake Nona
Professor & Director, Diabetes and Obesity Research Center
Cardiovascular Pathobiology Program

Dr. Kelly investigates the molecular control of mitochondrial function and fuel metabolism in developing and diseased heart and skeletal muscle.

Sepideh Khorasanizadeh, Ph.D.

Professor
Metabolic Disease Program

Dr. Khorasanizadeh's laboratory characterizes the epigenetic mechanisms that orchestrate transcription using tools of biophysics and structural biology.

Renate Koenig, Ph.D.

Adjunct Associate Professor

Masanobu Komatsu, Ph.D.

Associate Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Komatsu focuses on unveiling the molecular basis of blood vessel formation and developing novel strategies to treat vascular abnormalities associated with human diseases.

George Kyriazis, Ph.D.

Adjunct Professor
Metabolic Disease Program

George Kyriazis, Ph.D., is studying type 2 diabetes.

L

Sunyoung Lee, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Lee focuses on how vascular endothelial growth factor (VEGF) regulates specification, morphogenesis, differentiation and homeostasis of blood vessels, both in normal and pathological conditions.

Jean-Pyo Lee, 

Adjunct Assistant Professor

Fred Levine, M.D., Ph.D.

Professor & Director, Sanford Children’s Health Research Center
Human Genetics Program

Dr. Levine studies the process of pancreatic beta-cell regeneration, with the goal of developing new therapies for diabetes. Because tissue regeneration involves a balance between growth and differentiation, his work also has implications for cancer and the relationship between obesity and cancer.

Gianluigi Lichinchi, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Gianluigi is interested in understanding the mechanisms involving small RNAs and RNA-protein complexes in regulating HIV-1 cycle and host-pathogen interactions.

Robert Liddington, Ph.D.

Professor
Bioinformatics and Structural Biology Program

Dr. Liddington’s laboratory uses x-ray crystallography to explore the structural basis of host-pathogen interactions; the structure-function correlates of viral virulence; and the role of integrins in inflammation, hemostasis and cancer metastasis

Kenneth Liechty, M.D.

Adjunct Faculty
Cardiovascular Pathobiology Program

Stuart Lipton, M.D., Ph.D.

Professor & Director, Neuroscience and Aging Research Center
Degenerative Diseases Program

The Lipton laboratory studies molecular mechanisms of neurodegenerative diseases and stroke, including the role of excessive stimulation of ion channels and intracellular signaling pathways in nerve cells, develops new drug treatments for these conditions, and uses stem cells, molecularly engineered to become nerve cells, for cell-replacement therapy.

Sally Litherland, Ph.D.

Adjunct Associate Professor
Metabolic Disease Program

Jinsha Liu, M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Jinsha aims to investigate the role of CDH13 and explore possible mechanisms in neuronal networks.

Jeanne Loring, Ph.D.

Adjunct Professor

Dr. Loring's current research focuses on the molecular basis of pluripotence and differentiation of human embryonic stem (ES) cells.

M

Siobhan Malany, Ph.D.

Chemical Biology Team Leader
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Siobhan provides scientific consultation and execution of cell-based, organism-based, biochemical, phenotypic and stem-cell assays for HTS and drug discovery.

Francesca Marassi, Ph.D.

Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Marassi's laboratory uses solution-state and solid-state NMR spectroscopy to determine the three-dimensional structure of integral membrane proteins, which are potential therapeutic targets in cancer, heart disease and infectious disease.

Robert Margolis, Ph.D.

Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Margolis' research focuses on the relationships between mitosis, the cell cycle, and the cellular cytoskeleton, and the regulatory mechanisms that control them.

Jamey Marth, Ph.D.

Carbon Chair of Biochemistry and Molecular Biology, UCSB
Mellichamp Chair of Systems Biology, UCSB
Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

The Marth laboratory develops and applies interdisciplinary approaches in cell biology and biomedical research to discover the metabolic origins and mechanisms of common diseases and syndromes including diabetes, autoimmunity, inflammation, coagulopathy, and sepsis.

Marco Maruggi, B.S., M.Eng.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

My work revolves around understanding the impact of hypoxia on the DNA repair process, specifically in the context of resistance to targeted therapy to cancer.

Shu-Ichi  Matsuzawa, Ph.D.

Research Assistant Professor, NCI-Designated Cancer Center

Jochen Maurer, Ph.D.

Postdoctoral Fellow

Dr. Maurer studies cancer stem cells in breast cancer.

Wesley McKeithan, B.A.

Graduate Student

Wesley is focused on developing high throughput assays that measure cardiomyocyte action potential and calcium transient kinetics.

Philip McQuary, M.S.

Postdoctoral Fellow

Philip is exploring the role of the translation initiation factor eIF4E2 in protein synthesis under stressful environmental conditions.

Angel Mei, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Angel is interested in drug development through fragment based design using NMR.

Mark Mercola, Ph.D.

Professor
Development, Aging, and Regeneration Program

Dr. Mercola's research is directed at discovering new therapeutics for heart failure and cancer.

José Luis Millán, Ph.D.

Professor
Human Genetics Program

Dr. Millán studies the mechanisms that control normal skeletal mineralization and the pathophysiology of diverse calcification disorders, including vascular calcification.

Jorge Moscat, Ph.D.

Professor, NCI-Designated Cancer Center
Director, Cell Death and Survival Networks Program

Dr. Moscat studies the control of cancer metabolism and inflammation.

William Muller, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Tomas Mustelin, M.D., Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Mustelin investigates a family of genes called protein tyrosine phosphatase (PTPases), many of which act as tumor suppressors in numerous types of human cancer.

P

Goon Park, M.S.

, Sanford-Burnham Graduate School of Biomedical Sciences

Goon Ho is studying about molecular mechanism of parkinson disease.

Elena Pasquale, Ph.D.

Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Pasquale's research investigates the signaling pathways of Eph receptor tyrosine kinases and their ligands in order to understand their role in normal physiology and in pathological conditions such as cancer and neurological disorders.

Giovanni Paternostro, M.D., Ph.D.

Adjunct Assistant Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Paternostro's laboratory is employing a multidisciplinary, systems-biology approach to identify optimal combinatorial drug therapies for cancer, and to understand the cardiac and metabolic alterations caused by aging and hypoxia.

Maurizio Pellecchia, Ph.D.

Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Pellecchia is working to characterize the three dimensional structures and intermolecular interactions of protein targets involved in cell-signaling, cancer cell transformation and virulence factors, and on combining medicinal chemistry with structure- and fragment-based drug design, to aid in the development of novel therapeutic compounds.

Ranjan Perera, Ph.D.

Scientific Director, Analytical Genomics and Bioinformatics
Associate Professor
Metabolic Disease Program

Dr. Perera investigates the molecular mechanisms by which non-coding RNA might affect melanoma development in humans and identifying the link between obesity and cancer.

Cameron Pernia, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Cameron is interested in utilizing these stem cell tools to elucidate how changes in the molecular biology of the brain results in complex changes in behavior and cognition.

Manuel Perucho, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Perucho is studying the role of genetic and epigenetic alterations in the development of hereditary and nonhereditary gastrointestinal cancers.

Scott Peterson, Ph.D.

Professor
Bioinformatics and Structural Biology Program

Dr. Peterson studies microbes resident in the oral cavity, gut and prostate environments. He is equally interested in the potential of these microbiomes to maintain human health and as causative agents of disease, particularly cancer.

Matthew Petroski, Ph.D.

Associate Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Petroski studies how proteins are modified with ubiquitin and ubiquitin-like proteins.

Anthony  Pinkerton, Ph.D.

Director of Chemistry
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Dr. Pinkerton directs the hit to lead and lead optimization efforts of Conrad Prebys Center for Chemical Genomics.

Garth Powis, D.Phil.

Jeanne and Gary Herberger Leadership Chair in Cancer Research
Professor & Director, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Powis studies the mechanisms that enable cancer cells to survive stress.

Richard Pratley, M.D.

Adjunct Professor
Metabolic Disease Program

The Pratley lab focuses on the role of adipose tissue and adipocyte secreted products in the pathogenesis of type 2 diabetes and its complications.

Jeffrey Price, M.D., Ph.D.

Adjunct Associate Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Price's laboratory is focused on the development of fully automated, quantitative microscopy, or scanning cytometry, for biomedical applications. 

Pier Lorenzo Puri, M.D., Ph.D.

Associate Professor
Development, Aging, and Regeneration Program

Dr. Puri investigates the molecular mechanisms underlying the reprogramming of the genome during cell lineage commitment and terminal differentiation.

R

Tariq Rana, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

The Rana laboratory is studying the architecture and function of RNA Regulatory assemblies involved in stem cell creation and their fate decisions, RNA interference (RNAi), innate immunity, host-pathogen interactions, HIV-1 replication, and RNA therapeutics.

Barbara Ranscht, Ph.D.

Professor
Development, Aging, and Regeneration Program

The Ranscht laboratory investigates the molecular basis of cell-cell communication in the nervous- and cardiovascular system, and the nature of disrupted interactions in neurological-, cardiovascular and cancer pathologies.

Fraydoon Rastinejad, Ph.D.

Professor
Metabolic Disease Program

Dr. Rastinejad’s laboratory is interested in the nuclear hormone receptors that regulate metabolic pathways, and studies these transcription factors using  crystallographic, biochemical and small molecule approaches.

Eugene Redmond, 

Adjunct Professor

John C. Reed, M.D., Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Reed’s laboratory studies the fundamental mechanisms of cell life-span regulation, how the defective regulation of programmed cell death mechanisms result in disease, and the role of NLR-family proteins in innate immunity, inflammation and infectious disease.

Miguel Reina Campos, B.S., M.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Miguel’s research is mainly focused on the study of the role of atypical PKC’s pathway in cancer and cellular homeostasis thorough the identification of selective substrates for this PKC subfamily.

Tannishtha Reya, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Wanda Reynolds, Ph.D.

Associate Investigator

Dr. Reynolds studies the aberrant expression of MPO, an oxidant generating enzyme, in diseases of aging, and investigates how it contributes to neurodegenerative disease, atherosclerosis, and cancer.

Adam D. Richardson, Ph.D.

Facility Director, Cancer Metabolism Shared Resource
Research Assistant Professor, NCI-Designated Cancer Center

Dr. Richardson studies the role of tumor cell metabolism in tumor progression and metastasis.

Robert Rickert, Ph.D.

Director of Academic Affairs
Associate Dean, Graduate Program
Professor
Director, Tumor Microenvironment and Metastasis Program

Dr. Rickert's laboratory is working to better understand the molecular determinants of B lymphocyte differentiation in normal and disease states.

Stefan Riedl, Ph.D.

Associate Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Riedl research is centered on understanding the structure and mechanisms of signaling proteins as well as their complexes and signaling platforms in light of pathway regulation and disease.

Dmitry Rodionov, Ph.D.

Research Assistant Professor

Dr. Rodionov studies functional and comparative genomics of microbial genomes.

Ze'ev Ronai, Ph.D.

Scientific Director, Sanford-Burnham Medical Research Institute at La Jolla
Professor & Deputy Director, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Ronai's group is working to understand the regulation and function of mammalian stress-response signaling pathways.

Erkki Ruoslahti, M.D., Ph.D.

Distinguished Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Ruoslahti’s laboratory is investigating potential therapeutic targets in tumor vasculature using vascular and lymphatic homing peptides, and they also study the mechanisms by which metastatic tumor cells overcome adhesion-dependent survival signals.

S

Alessandra Sacco, Ph.D.

Assistant Professor
Development, Aging, and Regeneration Program

Dr. Sacco's laboratory is investigating the self-renewal mechanism of skeletal muscle stem cells and determining how this process applies to muscle degenerative diseases.

Sumeet Salaniwal, Ph.D.

Director, Informatics


Guy Salvesen, Ph.D.

Dean, Graduate School of Biomedical Sciences
Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Salvesen's research focuses on the central role of enzyme pathways in the intrinsic life span and death of cells.

Marisa Sanchez, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Marisa is studying how cells ensure their survival by adapting their gene expression in response to oxidative stress.

Takumi Satoh, Ph.D.

Adjunct Professor

Arnold Satterthwait, Ph.D.

Associate Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Satterthwait's laboratory is using synthetic peptidomimetics to mimic critical three-dimensional regions of proteins, assess new theories of disease at the molecular level and to develop diagnostic tests, cancer drugs, and vaccines.

Judith Scheliga, M.S.

Postdoctoral Fellow

Judith Scheliga focuses on elucidating the biochemical pathways controlled by eIF3e and on linking its loss during breast carcinogenesis to its potential role in stress-specific translation and apoptosis.

Peter Seeberger, Ph.D.

Adjunct Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Seeberger research is focused on elucidating the role of complex oligosaccharides involved in a host of biological processes of medical relevance by employing molecular tools created by synthetic chemistry.

Eduard Sergienko, Ph.D.

Director, Assay Development
Staff Scientist, Conrad Prebys Center for Chemical Genomics

Eduard provides scientific oversight of the HTS assay development and molecular pharmacology.

Attila Seyhan, Ph.D.

Adjunct Professor
Metabolic Disease Program

As a Faculty Scientist, Dr. Seyhan conducts Translational Research using “omics” molecular profiling technology platforms to understand pathogenesis and pathophysiology of diabetes, obesity, and metabolic origins of cardiovascular diseases with a particular interest in identifying and developing novel biomarkers, drug targets and mechanisms.

Khooshbu Shah, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Khooshbu is interested in re-creating ARVD/C in a dish with the use of induced pluripotent stem cells in order to evaluate potential therapies for the disease.

Hans Sieburg, 

Staff Scientist

Jeffrey Smith, Ph.D.

Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Smith’s laboratory is interested in developing new methods for proteomics, with implications for cancer and infectious diseases.

Layton Smith, Ph.D.

Director, Drug Discovery Florida
Assistant Professor
Cardiovascular Pathobiology Program

Dr. Smith studies the role of apelin and its receptor in cardiovascular function.

Steven Smith, M.D.

SVP / Chief Scientific Officer, Florida Hospital & Scientific Director,
Translational Research Institute for
Metabolism and Diabetes
Professor
Metabolic Disease Program

Dr. Smith’s research focuses on the control of metabolic substrate switching between fat and carbohydrate, with a particular emphasis on the regulation of fatty acid oxidation in skeletal muscle and the adipose tissue dysfunction that occurs in obesity.

David Smotrich, M.D.

Clinical Associate

Evan Snyder, M.D., Ph.D.

Professor
Human Genetics Program

Dr. Snyder's laboratory is using a multidisciplinary approach to exploring the basic biology of stem cells, their role throughout the lifetime of an individual, and their therapeutic potential in homeostasis and injury recovery.

Stephen Soonthornvacharin, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Stephen is interested in employing a systems-based approach, which will integrate a series of functional genomics analyses to identify novel molecular factors in RIG-I-dependent type-I interferon signaling.

Lauren Sparks, Ph.D.

Adjunct Professor
Metabolic Disease Program

Dr. Sparks conducts her work in the area of exercise and muscle metabolism.

Joachim Spiess, M.D., Ph.D.

Adjunct Professor

Charles Spruck, Ph.D.

Assistant Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Spruck studies the roles of ubiquitin-dependent proteolysis and cell cycle proteins in the regulation of cell division and tumor development.

William Stallcup, Ph.D.

Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

The Stallcup laboratory studies the cell surface protein NG2 and its role in the proliferation and motility of both normal and cancer cells.

Alex Strongin, Ph.D.

Professor
Bioinformatics and Structural Biology Program

Dr. Strongin's research focuses on the fundamental mechanisms by which proteolysis and proteinases enable cell migration, cell proliferation and tumor cell metastasis, and by which the host, viral and bacterial proteinases affect host-pathogen interactions.

Srikrishna Subramanian, Ph.D.

Adjunct Professor

Kazuki Sugahara , 

Research Assistant Professor, NCI-Designated Cancer Center

T

Lutz Tautz, Ph.D.

Research Assistant Professor, NCI-Designated Cancer Center
Cell Death and Survival Networks Program

Dr. Tautz is a chemical biologist—integrating the fields of organic and medicinal chemistry, biochemistry, and molecular and cell biology.

Tambet Teesalu, Ph.D.

Adjunct Assistant Professor, NCI-Designated Cancer Center
Tumor Microenvironment and Metastasis Program

Dr. Teesalu uses phage display screens to identify homing peptides that bind to specific targets in the vasculature.

Alexey Terskikh, Ph.D.

Associate Professor
Development, Aging, and Regeneration Program

Dr. Terskikh is interested in elucidating the mechanisms underlying self-renewing and differentiation decisions in normal and cancer stem cells.

Victoria Thaney, B.S.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Victoria’s research is focused on pathological processes associated with human immunodeficiency virus-1(HIV-1) infection, in particular HIV-1 associated dementia (HAD).

Matthew Tierney, M.A.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Matthew is interested in investigating the microenvironmental cues and cell-autonomous features that influence the regenerative potential of these different populations.

Tiara Tirasawasdichai, B.A.

Graduate Student, Sanford-Burnham Graduate School of Biomedical Sciences

Tiara will be studying the metabolic dysregulation of hypertrophic cardiomyopathy (HCM) using patient-specific iPSC-derived cardiomyocytes.

Dwight Towler, M.D., Ph.D.

Professor
Director, Cardiovascular Pathobiology Program

Dr. Towler's research focuses on fundamental and early translational aspects of cardiovascular biology, physiology, and disease.

Panagiotis Antonios Tsonis, Ph.D.

Adjunct Professor

Shichun Tu, Ph.D.

Research Assistant Professor

Dr. Tu studies neurological disorders focusing on the potential therapeutic benefits of the synaptic protein takusan, which he identified, in the treatment of Alzheimer’s disease (AD) and on the role of the transcription factor MEF2C in the pathogenesis of Autism Spectrum Disorders (ASD).

W

Xin Wang, B.S.

Postdoctoral Associate

Xin Wang is interested in the trafficking process of several important Alzheimer's disease (AD) related proteins, such as γ-secretase components, BACE1, APP and Neurotrophin receptors.

Carl Ware, Ph.D.

Director, Laboratory of Molecular Immunology
Professor & Director, Infectious and Inflammatory Disease Center
Immunity and Pathogenesis Program

Dr. Ware's research is directed at defining the intercellular communication pathways controlling immune responses, particularly to viral pathogens.

Robert Wechsler-Reya, Ph.D.

Professor, NCI-Designated Cancer Center
Director, Tumor Initiation and Maintenance Program

Dr. Wechsler-Reya’s group studies the signals that control cell growth and differentiation in the nervous system, and the manner in which these signals are dysregulated in brain tumors.

Dana Weekes, M.Eng.

Research Assistant Professor

Ms. Weekes focuses in developing novel ways of approaching data in biology, from integrating data management and data analysis to developing intuitive systems that could easily be used by bench biologists, to development of new data analysis algorithms that could identify new regularities and eventually lead to testable hypotheses.

Dieter Wolf, M.D.

Director, NCI-designated Cancer Center Proteomics Facility
Professor, NCI-Designated Cancer Center
Tumor Initiation and Maintenance Program

Dr. Wolf's research focuses on the postranscriptional regulation of tumor-suppressor protein abundance and function, both at the level of protein translation and during degradation by the ubiquitin-proteasome system.

Philip Wood, D.V.M., Ph.D.

Professor
Metabolic Disease Program

Dr. Wood applies a genetic approach to investigate the role of abnormal fatty acid metabolism in rare inherited diseases and obesity-related disorders.

John Wooley, M.D.

Adjunct Associate Professor

Sanford-Burnham Medical Research Institute was founded by scientists and is led by scientists. Our CEO, Perry Nisen, M.D., Ph.D., is a pioneer in taking discoveries of the causes of disease all the way to actual treatments. He has held science leadership roles in neuro-oncolgy research and led science and innovation initiatives for major pharmaceutical companies. Our president, Kristiina Vuori, M.D., Ph.D., runs a busy laboratory that is actively seeking to understand the underlying causes of cancer and other diseases and develop new medicines. Our world-class team of administrative leaders is also composed of working scientists.

Sanford-Burnham also has an Institute Advisory Board made up of leading researchers who help advance our scientific efforts. The Sanford-Burnham Board of Trustees, composed of community leaders with a passion for our work, provides strategic guidance so that our efforts remain on track and sustainable.



Board of Trustees



Founders

Dr. William H. and Lillian Fishman

 

Honorary Trustees

Roberta and Malin Burnham

Former Chairman, The Burnham Companies

Joseph C. Lewis

Founder, Tavistock Group

Conrad T. Prebys

Owner, Progress Construction & Management Company

T. Denny Sanford

Chairman and CEO, United National Corp.

Trustees and Officers

Gregory T. Lucier

Chairman, Sanford-Burnham Medical Research Institute
Former Chairman and Chief Executive Officer, Life Technologies

 

Perry Nisen, M.D., Ph.D.

Chief Executive Officer, Sanford-Burnham Medical Research Institute
Donald Bren Chief Executive Chair

 

Kristiina Vuori, M.D., Ph.D.

President, Sanford-Burnham Medical Research Institute
Professor, NCI-Designated Cancer Center
Pauline and Stanley Foster Presidential Chair

Gary F. Raisl, M.B.A., Ed.D.

Executive Vice President
Chief Administrative Officer
Chief Financial Officer
Treasurer

Lorenzo M. Berho

Founder, Chairman & President, VESTA

 

James C. Blair, Ph.D.

Partner, Domain Associates

 

David W. Down

Managing Partner, KPMG LLP

 

Daniel J. Epstein

President, The ConAm Group

 

M. Wainwright Fishburn Jr.

Partner, Cooley LLP

 

Pauline M. Foster

President, Foster Investment Corporation

 

Patrick J. Geraghty

CEO, Florida Blue

 

William Gerhart

Chairman & CEO, Bernoulli Pharma Holdings

 

Alan A. Gleicher

Independent Investment Management Professional

 

Jeanne L. Herberger, Ph.D.

Vice President, Herberger Enterprises, Inc.

 

Donald L. Jernigan, Ph.D.

President and CEO, Adventist Health System

 

J. Bernard Machen, D.D.S., M.S., Ph.D.

President, University of Florida

 

Papa Doug Manchester

Chairman of the Board Manchester Financial Group, L.P.

 

Henry L. Nordhoff

Director, MannKind Corp.

 

Douglas H. Obenshain

Member, Lockton Companies

 

Edward R. Schulak

President, Edward Schulak Equities LLC

 

Rasesh Thakkar

Senior Managing Director, Tavistock Group

 

Luder G. Whitlock Jr.

Executive Director, CNL Charitable Foundation & Seneff Family Foundation

 

Institute Scientific Advisory Board



Bruce Beutler, M.D.

Director, Center for the Genetics of Host Defenses
UT Southwestern Medical Center
Dallas, TX

Gregory J. Gores, M.D.

Reuben R. Eisenberg Endowed Professor of Medicine and Physiology
Executive Dean for Research at the Mayo Clinic College of Medicine
Distinguished Investigator of the Mayo Foundation
Past Chair of the Division of Gastroenterology and Hepatology

Nikola Pavletich, Ph.D.

Chair, Structural Biology Program
Memorial Sloan-Kettering Cancer Center
New York, NY

Christopher B. Newgard, Ph.D.

W. David and Sarah W. Stedman Distinguished Professor
Duke University Medical Center
Durham, NC

Pierluigi Nicotera, M.D., Ph.D.

Scientific Director of the German Center for Neurodegenerative Diseases (DZNE)
Professor of Neurodegenerative Diseases at the University of Bonn

Victor Nizet, M.D.

Director, Division of Pharmacology & Drug Discovery
University of California, San Diego School of Medicine
La Jolla, CA

Kristiina Vuori, M.D., Ph.D.

President, Sanford-Burnham Medical Research Institute
Professor, NCI-Designated Cancer Center
Pauline and Stanley Foster Presidential Chair

Eric J. Topol, M.D.

Director, Scripps Translational Science Institute (STSI)
Chief Academic Officer, Scripps Health
La Jolla, CA

Jean Y.J. Wang, Ph.D.

Moores-UCSD Cancer Center
University of California, San Diego
La Jolla, CA

Paul A. Wender, Ph.D.

Bergstrom Professor, Department of Chemistry
Stanford University
Palo Alto, CA

Cancer Center External Advisory Board

External advice regarding the scientific programs of the Cancer Center is provided by the CCEAB. CCEAB members are recognized leaders in areas of research relevant to the Center, have broad interest and knowledge in cancer research, and bring forth significant administrative and leadership expertise.

CCEAB is chaired by Dr. Frank McCormick, who is the Director of the UCSF Helen Diller Family Comprehensive Cancer Center. Additional members include Drs. David Scheinberg, Robert Diasio, Kenneth Tew, William Dalton, Tony Hunter, Jean Wang, and Ms. Kisa Sideras.

CCEAB meets annually to review the Center, its programs, newly recruited faculty and proposed future goals, including the Five Year Scientific Plan. The CCEAB submits a written report to the Director, who shares the report with members of PPG and implements the CCEAB recommendations, as applicable.

The CCEAB guidance led to the establishment of the current three programs, and helped to shape the strategic emphasis areas within each program. The Center Director also consults with CCEAB members regarding leadership appointments within the Center, and the CCEAB members have endorsed the appointments of the new Associate Directors and Program Leaders during the past funding period.


Frank McCormick, Ph.D., F.R.S.

Cancer Center External Advisory Board Chair
Director, UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

David A. Scheinberg, M.D., Ph.D.

Director, Sloan-Kettering Research Institute
Memorial Sloan-Kettering Cancer Center
New York, NY

David A. Scheinberg, M.D., Ph.D. is currently Vincent Astor Chair, and Chairman, Molecular Pharmacology and Chemistry Program, Sloan-Kettering Institute. He also founded and Chairs the Experimental Therapeutics Center, and founded and was Chair of the Nanotechnology Center from 2010 to 2014. He is additionally Professor of Medicine and Pharmacology and Co-chair of the Pharmacology graduate program at the Weill-Cornell University Medical College and Professor in the Gerstner-Sloan Kettering Graduate School at MSKCC. He is a founder and Director of the Therapeutics Discovery Institute, a non profit drug discovery corporation formed with Weill Cornell Medical College, Rockefeller University and Sloan Kettering Institute. From 1992 until 2003, he was Chief of the Leukemia Service at Memorial Hospital. He has been elected into the American Society of Clinical Investigation (ASCI), the American Association of Physicians (AAP), and the Interurban Club. His other awards include the Doris Duke Distinguished Clinical Science Professorship, the Lucille P. Markey Scholarship, The Emil J. Freireich Award, Leukemia and Lymphoma Society Translational Investigator Awards, and CapCure Awards. He is an advisor to charitable foundations and cancer centers and sits on the Boards of Directors of public and private biotech companies. Dr. Scheinberg is a physician-scientist, specializing in the care of patients with leukemia and also investigating new therapeutic approaches to cancer, both in the hospital and in the laboratory. The focus of his research is on the discovery and development of novel, specific immuno-therapeutic agents. This includes monoclonal antibodies that target cell surface or intracellular proteins of cancers, targeted radiopharmaceuticals that deliver radioactive particles including alpha particles or alpha particle nanogenerators, and targeted nano-devices for selective cell kill, and therapeutic vaccines targeting the oncogene products that cause the cancers. Eight different therapeutic agents developed by Dr. Scheinberg in his laboratory have reached human clinical trials, which include the first humanized antibodies to treat acute leukemia, the first targeted alpha particle therapies and alpha generators, and the first tumor specific fusion oncogene product vaccines. His laboratory is also investigating cellular resistance mechanisms to these agents. Dr. Scheinberg has published more than 250 papers, chapters, or books in these fields.

Robert B. Diasio, M.D.

Director, Mayo Clinic Cancer Center
Rochester, MN

Dr. Diasio became the Director of the Mayo Clinic Cancer Center on September 1, 2006. At Mayo Clinic he also holds the position of William J. and Charles H. Mayo Professor, as well as Consultant and Professor of Molecular Pharmacology & Experimental Therapeutics and Oncology. Dr. Diasio received his undergraduate degree from the University of Rochester and subsequently the M.D. degree from Yale University School of Medicine in 1971. Following training in internal medicine at Strong Memorial Hospital in Rochester, NY, Dr. Diasio was a Fellow on the Medicine Branch at the National Cancer Institute in Medical Oncology and later in Clinical Pharmacology. From 1976 until 1984, Dr. Diasio served initially as an Assistant Professor and then subsequently as an Associate Professor in both the Departments of Medicine and Pharmacology at the Medical College of Virginia. In 1984, he moved to Birmingham, AL, where he was appointed Professor in the Departments of Medicine and Pharmacology, as well as Newman H. Waters Chair and Director of the Division of Clinical Pharmacology at the University of Alabama School of Medicine. In 1989, he was appointed Chair of the Department of Pharmacology and Toxicology and in 1997 Associate Director for Basic Sciences of the UAB Comprehensive Cancer Center.

Dr. Diasio is the author of more than two hundred manuscripts and invited reviews. He has authored chapters in several major medical textbooks including the 19th, 20th, 21st, 22nd, 23rd, and 24th editions of the Cecil Textbook of Medicine, 9th edition of Goodman & Gilman’s Textbook of Pharmacology - The Pharmacological Basis of Therapeutics, and the 6th and 7th editions of Holland and Frei Cancer Medicine. He has been an invited speaker at numerous national and international meetings on cancer pharmacology/oncology and was the principal organizer and chair of the 2005 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Meeting. Dr. Diasio has been the recipient of continuous R01 funding from the National Cancer Institute since 1978, and is the recipient of the highly competitive NCI MERIT award. He has served in the past on several editorial boards, including Cancer Medicine, Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, and Clinical Colorectal Cancer. He has also been an associate editor of Clinical Pharmacology and Therapeutics. Dr. Diasio has been a member of the NIH Experimental Therapeutics I Study Section and the NCI Cancer Center Support Grant Study Section (Subcommittee A), which he chaired for two years. In 2008, he was appointed to the Board of Scientific Advisors of the NCI, which advises the NCI Director on all aspects of the extramural programs, including present and future scientific directions. In 2009, he was elected to the Board of Directors of the Association of American Cancer Institutes. He is an active member of several academic societies, including the American Society of Clinical Oncology, the American Association for Cancer Research, and the American Society for Clinical Pharmacology and Therapeutics. In 1989, he was elected as a member of the American Society for Clinical Investigation and in 1998 he was elected to the Association of American Physicians - two of the nation's oldest and most respected medical honor societies. In 2009, he was elected a Fellow of the American Association for the Advancement of Science. His clinical interest continues to be in the area of gastrointestinal oncology, with particular interest in the predictive and prognostic role of genomic biomarkers. His basic research interest has focused mainly on the area of cancer pharmacogenetics/pharmacogenomics. Dr. Diasio has made important contributions in initially characterizing the pharmacogenetic syndrome of dihydropyrimidine dehydrogenase (DPD) deficiency and subsequently developing genomic tests to predict DPD deficiency.

Kenneth Tew, Ph.D., D.S.c.

Professor and Chairman, Hollings Cancer Center
Medical University of South Carolina
Charleston, SC

Kenneth D. Tew, Ph.D. is Professor and Chair of the Department of Cell & Molecular Pharmacology at MUSC and holds the John C. West Endowed Chair in Cancer Research, which is supported by the South Carolina SmartState Center of Excellence in Translational Cancer Therapeutics. He currently serves on the editorial boards of ten journals and is associate editor for JPET, senior editor for Cancer Research, and, in 2011, co-serial editor for Advances in Cancer Research. Dr. Tew’s credentials include election as a fellow of the American Association for the Advancement of Science (AAAS), election as chair of the Section of Pharmaceutical Sciences AAAS (2012-2015); Chair of Drug Discovery and Development Section of ASPET (2011-2013); and the Astellas USA Foundation Award 2010. Dr. Tew has extensive experience in the discovery and development of anti-cancer drugs with continuous peer-reviewed grant support since 1980. Dr. Tew’s scientific contributions to the field of cancer drug discovery and development focus on the involvement of redox pathways glutathione S-transferases in tumor cell resistance to anticancer drugs.

William S. Dalton, M.D.

CEO, M2GEN
Tampla, FL

Dr. Dalton was the Founding Director of the Bone Marrow Transplant Program at the University of Arizona. He is now the Chief executive Officer and Center Director of the H. Lee Moffit Cancer Center & Reserch Institute. Dr Dalton received his Ph.D. from Indianan University in Toxicology & Medical Life Sciences.

Dr. Dalton has been involved in cancer research for two decades . His research interests include biochemical mechanisms of drug resistance and new drug discovery. He is also an expert in the biology and treatment of multiple myeloma.

Tony Hunter, Ph.D.

Professor and Director, Cancer Center
Salk Institute for Biological Studies

Tony Hunter, a professor in the Molecular and Cell Biology Laboratory and director of the Salk Institute Cancer Center, studies how cells regulate their growth and division, and how mutations in genes that regulate growth lead to cancer. His lab has made significant contributions in the area of signal transduction, how signals that stimulate or rein in growth are routed within a cell. This knowledge already has resulted in a new approach to cancer treatment.

Jean Y. J. Wang, Ph.D.

Distinguished Professor, Asscociate Director of Basic Research
Moores UCSD Cancer Center
La Jolla, CA

Dr. Wang received her Ph.D. in Biochemistry from U.C. Berkeley and was a Jane Coffin Child postdoctoral fellow at MIT. Honors include the Searle Scholar Award, a MERIT Award from the National Cancer Institute (NCI), and the Herbert Stern Endowed Chair. Dr. Wang is Associate Director of Basic Research for the UCSD Cancer Center and an editor for the journal Molecular and Cellular Biology. She has been elected to the Board of Directors of the American Association for Cancer Research and has served on the NCI Board of Scientific Counselors.

Lisa Sideras

The Wistar Institute Cancer Center

Lisa Sideras has served as the Associate Director for Administration at the Wistar Institute Cancer Center since 2003. Ms. Sideras is responsible for administrative oversight of all aspects of the Cancer Center Support Grant, including the coordination of activities related to Cancer Center membership, research programs and shared resources. Ms. Sideras is a member of the Cancer Center Administrators Forum and sits on the external advisory boards of two other basic NCI-designated Cancer Centers.

Del E. Webb Neuroscience, Aging and Stem Cell Research Center Scientific Advisory Board



Jonathan Epstein, M.D.

University of Pennsylvania

 

Rudolph Tanzi, Ph.D.

Massachusetts General Hospital

 

Torsten Wiesel, M.D.

President Emeritus, Department of Neurobiology
Rockefeller University

 

Don Price, M.D.

Johns Hopkins University School of Medicine

 

Gordon Keller, Ph.D.

McEwen Centre for Regenerative Medicine

 

Eric Olson, Ph.D.

University of Texas at Southwestern

 

Rudolph Jaenisch, M.D.

Massachusetts Institute of Technology

 

Cynthia Kenyon, Ph.D.

University of California, San Francisco

 

Stephen Heinemann, Ph.D.

Salk Institute for Biological Studies

 

Floyd Bloom, M.D.

The Scripps Research Institute

 

Diabetes and Obesity Research Center Scientific Advisory Board



Christopher B. Newgard, Ph.D.

Director & Distinguished Professor
W. David & Sarah W. Stedman Nutrition and Metabolism Center,
Duke University Medical Center
Professor, Internal Medicine, Pharmacology, and Cancer Biology
Duke University

Alan D. Attie, Ph.D.

Professor, Department of Biochemistry
University of Wisconsin-Madison

Leslie A. Leinwand, Ph.D.

Professor and Chair, Department of Molecular, Cellular & Developmental Biology
University of Colorado at Boulder

David E. Moller, M.D.

Vice President, Endocrine & Cardiovascular Research & Clinical Investigation
Eli Lilly & Company

David D. Moore, Ph.D.

Professor, Department of Molecular & Cellular Biology
Baylor College of Medicine

Michael D. Schneider, Ph.D.

Professor, Head of Cardiovascular Sciences, and Chair in Cardiology
National Heart and Lung Institute
Imperial College, London

Administrative Leadership



Executive Administrative Leadership



Perry Nisen, M.D., Ph.D.

Chief Executive Officer, Sanford-Burnham Medical Research Institute
Donald Bren Chief Executive Chair

(858)646-3100 x3181   pnisen@sanfordburnham.org

Kristiina Vuori, M.D., Ph.D.

President, Sanford-Burnham Medical Research Institute

Professor, NCI-designated Cancer Center

Pauline and Stanley Foster Presidential Chair

(858)646-3100 x3127   kvuori@sanfordburnham.org

Gary F. Raisl, M.B.A., Ed.D.

Executive Vice President

Chief Administrative Officer, Chief Financial Officer, Treasurer

(858)646-3126   graisl@sanfordburnham.org

Administration



Michael Dollar

Vice President, Finance at Lake Nona

(407)745-2052   mdollar@sanfordburnham.org

Robin Ryan

Vice President, Finance

Controller

(858)795-5244   rryan@sanfordburnham.org

External Relations



Paul Baker

Vice President, Philanthropy

(407)745-2148   pbaker@sanfordburnham.org

Philip Graham, M.B.A

Vice President, Institutional Advancement

(858)795-5210   pgraham@sanfordburnham.org

Deborah Robison

Vice President, Communications

(407)745-2073   drobison@sanfordburnham.org

Scientific Leadership



Executive Scientific Leadership

Kristiina Vuori, M.D., Ph.D.

President, Sanford-Burnham Medical Research Institute

Professor, NCI-Designated Cancer Center

Pauline and Stanley Foster Presidential Chair

Dan Kelly, M.D.

Scientific Director, Sanford-Burnham at Lake Nona

Director and Professor, Diabetes and Obesity Research Center

Ze'ev Ronai, Ph.D.

Scientific Director, Sanford-Burnham at La Jolla

Associate Director, NCI-designated Cancer Center

Disease-Focused Center Directors

Garth Powis, Ph.D.

Director and Professor, NCI-Designated Cancer Center

Stuart Lipton, M.D., Ph.D.

Director and Professor, Del E. Webb Neuroscience, Aging and Stem Cell Research Center


Carl Ware, Ph.D.

Director and Professor, Infectious and Inflammatory Disease Center


Dan Kelly, M.D.

Scientific Director, Sanford-Burnham at Lake Nona

Director and Professor, Diabetes and Obesity Research Center


Fred Levine, M.D., Ph.D.

Director and Professor, Sanford Children's Health Research Center


Emerging Center Directors

Evan Snyder, M.D., Ph.D.

Director and Professor, Center for Stem Cell Biology and Regenerative Medicine


Program Directors

Robert Wechsler-Reya, Ph.D.

Program Director and Professor, Tumor Initiation and Maintenance


Jorge Moscat, Ph.D.

Program Director and Professor, Cell Death and Survival Networks


Sara Courtneidge, Ph.D.

Program Director and Professor, Tumor Microenvironment and Metastasis

Director, Academic Affairs


Randal Kaufman, Ph.D.

Program Director and Professor, Proteostasis and Neurodegeneration


Robert Rickert, Ph.D.

Program Director and Professor, Immunity and Pathogenesis


Hudson Freeze, Ph.D.

Program Director and Professor, Human Genetics